Skip to main content
. 2022 Jun 6;9:878211. doi: 10.3389/fcvm.2022.878211

Table 1.

Patients' characteristics at inclusion.

Patients' characteristics Whole cohort
N = 99 (%)
General
Mean age (years) 64
Male gender 51 (52%)
Risk factor Smoking
No 10 (10%)
Cessation >3years 40 (40%)
Current 49 (49%)
Preexisting cardiovascular diseases
Coronary artery disease 14 (14%)
Other artery disease 11 (11%)
Arrhythmia/Conduction abnormality 13 (13%)
Heart failure
LVEF <40% 1 (1%)
LVEF 40–50% 6(6%)
LVEF >50% 8(8%)
Cardiovascular risk factors
Age (male >50 years; female >60 years) 80 (81%)
Diabetes mellitus 19 (19%)
Dyslipidaemia 32 (32%)
Hypertension 18 (18%)
Primary cancer type Adenocarcinoma 65 (66%)
Squamous cell carcinoma 17 (17%)
Small cell lung cancer 12 (12%)
Others 5 (5%)
Pre-ICI biomarkers Positive serum troponin before ICI 6 (6%)
Troponin (ng/l) 13+/−21μ
BNP (pg/ml) 44+/−41π
NT-pro-BNP (pg/ml) 341+/−448Ω
CPK (UI/l) 64+/−55
Pre-ICI ECG PR (ms) 153+/−27
QRS (ms) 94+/−21Inline graphic
Pre-ICI TTE LVEG (%) 61%+/−6.5%Inline graphic
Strain (%) −18%+/−3.1%Inline graphic
S'VD (cm/s) 13.6+/−2.66Inline graphic

Missing data :

μ

= 8 (8%),

π

= 25 (25%),

= 14 (14%),

= 11 (11%),

Inline graphic =9 (9%), Inline graphic = 2 (2%), Inline graphic = 39 (39%), Inline graphic = 14 (14%)Patients concerned :

Ω

= 15 (15%).

ECG, electrocardiogram; ICI, Immune checkpoint inhibitors; TTE, Transthoracic echocardiogram; LVEG, Left ventricular ejection fraction.

Data were expressed as mean +/- standard deviation, as appropriate.